Table 3.
Summary of patient preference for the ELLIPTA DPI relative to specified other inhalers
| Comparator device | No. of patients using comparator device | No. (%) of patients expressing preference for the ELLIPTA DPI |
|---|---|---|
|
Total | ||
| DISKUS |
42 |
33 (79) |
| MDI/HFA |
30 |
23 (77) |
| HandiHaler |
20 |
19 (95) |
|
Asthma | ||
| DISKUS |
21 |
15 (71) |
| MDI/HFA |
10 |
6 (60) |
|
COPD | ||
| DISKUS |
21 |
18 (86) |
| MDI/HFA |
20 |
17 (85) |
| HandiHaler | 20 | 19 (95) |
COPD = chronic obstructive pulmonary disorder; DPI = dry powder inhaler; HFA = hydrofluoroalkane (propellant); MDI = metered dose inhaler.